学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines
被引:7
作者
:
Mitsiades, CS
论文数:
0
引用数:
0
h-index:
0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
Mitsiades, CS
Sykoutri, D
论文数:
0
引用数:
0
h-index:
0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
Sykoutri, D
McMullan, C
论文数:
0
引用数:
0
h-index:
0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
McMullan, C
Poulaki, V
论文数:
0
引用数:
0
h-index:
0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
Poulaki, V
论文数:
引用数:
h-index:
机构:
Mitsiades, N
机构
:
[1]
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2]
Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab, Boston, MA 02114 USA
来源
:
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
|
2003年
/ 88卷
/ 10期
关键词
:
D O I
:
10.1210/jc.2003-030968
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
[No abstract available]
引用
收藏
页码:5043 / 5044
页数:2
相关论文
共 7 条
[1]
Bcr-Abl inhibition as a modality of CML therapeutics
Buchdunger, E
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth & Sci Univ, Portland, OR 97201 USA
Buchdunger, E
Matter, A
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth & Sci Univ, Portland, OR 97201 USA
Matter, A
Druker, BJ
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth & Sci Univ, Portland, OR 97201 USA
Druker, BJ
[J].
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER,
2001,
1551
(01):
: M11
-
M18
[2]
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, BJ
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Druker, BJ
Tamura, S
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Tamura, S
Buchdunger, E
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Buchdunger, E
Ohno, S
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Ohno, S
Segal, GM
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Segal, GM
Fanning, S
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Fanning, S
Zimmermann, J
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Zimmermann, J
Lydon, NB
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Lydon, NB
[J].
NATURE MEDICINE,
1996,
2
(05)
: 561
-
566
[3]
Druker BJ, 2002, J NATL CANCER I, V94, P1660
[4]
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
Druker, BJ
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Druker, BJ
Talpaz, M
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Talpaz, M
Resta, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Resta, DJ
Peng, B
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Peng, B
Buchdunger, E
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Buchdunger, E
Ford, JM
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Ford, JM
Lydon, NB
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Lydon, NB
Kantarjian, H
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Kantarjian, H
Capdeville, R
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Capdeville, R
Ohno-Jones, S
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Ohno-Jones, S
Sawyers, CL
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Sawyers, CL
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
2001,
344
(14)
: 1031
-
1037
[5]
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL(+) leukemic cells and induces apoptosis
GambacortiPasserini, C
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
GambacortiPasserini, C
leCoutre, P
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
leCoutre, P
Mologni, L
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Mologni, L
Fanelli, M
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Fanelli, M
Bertazzoli, C
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Bertazzoli, C
Marchesi, E
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Marchesi, E
DiNicola, M
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
DiNicola, M
Biondi, A
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Biondi, A
Corneo, GM
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Corneo, GM
Belotti, D
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Belotti, D
Pogliani, E
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Pogliani, E
Lydon, NB
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Lydon, NB
[J].
BLOOD CELLS MOLECULES AND DISEASES,
1997,
23
(19)
: 380
-
394
[6]
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
Kantarjian, H
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Kantarjian, H
Sawyers, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Sawyers, C
论文数:
引用数:
h-index:
机构:
Hochhaus, A
Guilhot, F
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Guilhot, F
Schiffer, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Schiffer, C
Gambacorti-Passerini, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Gambacorti-Passerini, C
Niederwieser, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Niederwieser, D
Resta, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Resta, D
Capdeville, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Capdeville, R
Zoellner, U
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Zoellner, U
Talpaz, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Talpaz, M
论文数:
引用数:
h-index:
机构:
Druker, B
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
2002,
346
(09)
: 645
-
652
[7]
The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cells
Podtcheko, A
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Podtcheko, A
Ohtsuru, A
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Ohtsuru, A
Tsuda, S
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Tsuda, S
Namba, H
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Namba, H
Saenko, V
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Saenko, V
Nakashima, M
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Nakashima, M
Mitsutake, N
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Mitsutake, N
Kanda, S
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Kanda, S
Kurebayashi, J
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Kurebayashi, J
Yamashita, S
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Yamashita, S
[J].
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,
2003,
88
(04)
: 1889
-
1896
←
1
→
共 7 条
[1]
Bcr-Abl inhibition as a modality of CML therapeutics
Buchdunger, E
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth & Sci Univ, Portland, OR 97201 USA
Buchdunger, E
Matter, A
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth & Sci Univ, Portland, OR 97201 USA
Matter, A
Druker, BJ
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth & Sci Univ, Portland, OR 97201 USA
Druker, BJ
[J].
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER,
2001,
1551
(01):
: M11
-
M18
[2]
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, BJ
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Druker, BJ
Tamura, S
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Tamura, S
Buchdunger, E
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Buchdunger, E
Ohno, S
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Ohno, S
Segal, GM
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Segal, GM
Fanning, S
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Fanning, S
Zimmermann, J
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Zimmermann, J
Lydon, NB
论文数:
0
引用数:
0
h-index:
0
机构:
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND
Lydon, NB
[J].
NATURE MEDICINE,
1996,
2
(05)
: 561
-
566
[3]
Druker BJ, 2002, J NATL CANCER I, V94, P1660
[4]
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
Druker, BJ
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Druker, BJ
Talpaz, M
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Talpaz, M
Resta, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Resta, DJ
Peng, B
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Peng, B
Buchdunger, E
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Buchdunger, E
Ford, JM
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Ford, JM
Lydon, NB
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Lydon, NB
Kantarjian, H
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Kantarjian, H
Capdeville, R
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Capdeville, R
Ohno-Jones, S
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Ohno-Jones, S
Sawyers, CL
论文数:
0
引用数:
0
h-index:
0
机构:
Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
Sawyers, CL
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
2001,
344
(14)
: 1031
-
1037
[5]
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL(+) leukemic cells and induces apoptosis
GambacortiPasserini, C
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
GambacortiPasserini, C
leCoutre, P
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
leCoutre, P
Mologni, L
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Mologni, L
Fanelli, M
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Fanelli, M
Bertazzoli, C
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Bertazzoli, C
Marchesi, E
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Marchesi, E
DiNicola, M
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
DiNicola, M
Biondi, A
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Biondi, A
Corneo, GM
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Corneo, GM
Belotti, D
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Belotti, D
Pogliani, E
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Pogliani, E
Lydon, NB
论文数:
0
引用数:
0
h-index:
0
机构:
IST NAZL TUMORI,DIV EXPT ONCOL D & MED ONCOL C,I-20133 MILAN,ITALY
Lydon, NB
[J].
BLOOD CELLS MOLECULES AND DISEASES,
1997,
23
(19)
: 380
-
394
[6]
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
Kantarjian, H
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Kantarjian, H
Sawyers, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Sawyers, C
论文数:
引用数:
h-index:
机构:
Hochhaus, A
Guilhot, F
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Guilhot, F
Schiffer, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Schiffer, C
Gambacorti-Passerini, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Gambacorti-Passerini, C
Niederwieser, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Niederwieser, D
Resta, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Resta, D
Capdeville, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Capdeville, R
Zoellner, U
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Zoellner, U
Talpaz, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Talpaz, M
论文数:
引用数:
h-index:
机构:
Druker, B
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
2002,
346
(09)
: 645
-
652
[7]
The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cells
Podtcheko, A
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Podtcheko, A
Ohtsuru, A
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Ohtsuru, A
Tsuda, S
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Tsuda, S
Namba, H
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Namba, H
Saenko, V
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Saenko, V
Nakashima, M
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Nakashima, M
Mitsutake, N
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Mitsutake, N
Kanda, S
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Kanda, S
Kurebayashi, J
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Kurebayashi, J
Yamashita, S
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
Yamashita, S
[J].
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,
2003,
88
(04)
: 1889
-
1896
←
1
→